Core Viewpoint - The Ensign Group, Inc. has expanded its portfolio by acquiring two skilled nursing facilities, enhancing its presence in Texas and Arizona, and reaffirming its strategy to seek further acquisition opportunities in the healthcare sector [1][5]. Group 1: Acquisitions - The Ensign Group acquired "The Chateau Waco," a 123-bed skilled nursing facility in Waco, Texas, effective February 1, 2026, through its subsidiary Standard Bearer Healthcare REIT, Inc. [1] - In addition, the company acquired "Agave Grove Post Acute," a 225-bed skilled nursing facility located in Glendale, Arizona, also effective February 1, 2026 [4]. - These acquisitions bring Ensign's total healthcare operations to 378 across 17 states, including 47 senior living operations [5]. Group 2: Operational Strategy - Barry Port, CEO of Ensign, expressed enthusiasm about adding the new facility to their Texas operations, highlighting Texas as a mature market for the company [2]. - Andy Ashton, President of Keystone Care LLC, emphasized the commitment to combine efforts with existing staff to provide exceptional service to patients [3]. - The company is actively seeking opportunities to acquire both well-performing and struggling skilled nursing and senior living facilities throughout the United States [5]. Group 3: Real Estate Holdings - Ensign subsidiaries, including Standard Bearer, currently own 160 real estate assets as part of their growing portfolio [5]. - The company operates a broad spectrum of healthcare services across various states, indicating a diverse operational footprint [6].

SAN JUAN CAPISTRANO, Calif., Feb. 03, 2026 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it acquired the real estate and operations of “Wylie Oaks Healthcare and Rehabilitation”, a 106-bed skilled nursing facility located in Wylie, Texas. The r ...

Core Viewpoint - The Ensign Group, Inc. is set to release its fourth quarter and fiscal year 2025 financial results on February 4, 2026, followed by a conference call on February 5, 2026, to discuss the performance [1][2]. Company Overview - The Ensign Group, Inc. operates independent subsidiaries that provide a wide range of services including skilled nursing, senior living, and various rehabilitative healthcare services across 373 facilities in multiple states [4]. Financial Communication - A live webcast will be available for investors to listen to the discussion of the financial results, which will also be recorded for later access until February 27, 2026 [2][3]. Investor Relations - For further information, investors can visit the Ensign Group's investor relations website [3]. Contact details for investor and media relations are also provided [7].

Core Insights - The Ensign Group, Inc. (ENSG) benefits from improved service revenues, active acquisition strategies, and a strong financial position, with a history of 23 consecutive years of dividend increases reinforcing investor confidence [1][14] Financial Performance - Ensign Group currently holds a Zacks Rank 3 (Hold) and has seen a stock price increase of 31.9% over the past year, outperforming the industry growth of 29.3% [2] - The Zacks Consensus Estimate for Ensign Group's 2025 earnings is $6.50 per share, reflecting an 18.2% increase from the previous year, while revenues are projected at $5.1 billion, indicating an 18.9% rise [5] - The consensus for 2026 earnings is $7.09 per share, representing a 9% growth from the 2025 estimate, with revenues expected to reach $5.6 billion, an 11.3% increase [7] Growth Drivers - Revenue growth is primarily driven by skilled nursing, rehabilitation, and senior living service expansions, supported by strategic acquisitions in Colorado, Kansas, and Arizona [6][10] - Ensign operates 373 facilities and owns 156 real estate assets, leveraging a strong cash position to support growth and dividend payments [6][14] - The aging U.S. population and increasing demand for effective rehabilitation services are expected to significantly contribute to revenue growth in the Skilled Services segment [10] Operational Efficiency - Ensign Group has a return on equity of 18.5%, significantly higher than the industry's negative return of 17.7%, indicating effective utilization of shareholders' funds [9] - The Standard Bearer segment generates consistent rental income through triple-net lease agreements, enhancing operational efficiency by shifting property-related costs to tenants [11] Acquisition Strategy - Ensign's aggressive acquisition strategy focuses on expanding its footprint across the U.S., allowing for better regional healthcare service delivery [12][13] - Recent acquisitions include four skilled nursing facilities in December 2025, further enhancing Ensign's healthcare portfolio [13]

Company Performance - AtriCure (ATRC) has gained approximately 32.7% year-to-date, significantly outperforming the average gain of 7.7% for Medical stocks [4] - The Zacks Consensus Estimate for AtriCure's full-year earnings has increased by 32.9% over the past quarter, indicating improved analyst sentiment and earnings outlook [3] Industry Comparison - AtriCure is part of the Medical - Products industry, which consists of 83 individual stocks and currently ranks 182 in the Zacks Industry Rank. This industry has seen an average gain of 1.9% year-to-date, further highlighting AtriCure's strong performance [5] - In contrast, the Medical - Nursing Homes industry, which includes Ensign Group (ENSG), has gained 31.7% year-to-date and is ranked 23 [6] Sector Ranking - AtriCure is a member of the Medical group, which includes 946 companies and currently holds the 4 position in the Zacks Sector Rank [2] - The Zacks Rank system, which emphasizes earnings estimates and revisions, currently assigns AtriCure a Zacks Rank of 2 (Buy), indicating a favorable outlook for the stock [3]

Core Insights - The Ensign Group, Inc. (ENSG) has increased its quarterly dividend to 6.5 cents per share, marking a 4% increase from the previous 6.25 cents, and extending its record of dividend growth to 23 consecutive years [1][2][9] - The company has achieved an annualized dividend growth rate of 4.3% over the past five years, with a current dividend yield of 0.15%, surpassing the industry average of 0.11% [1][2] - Ensign's strong financial position is highlighted by $443.7 million in cash and cash equivalents and a low long-term debt-to-capital ratio of 6.1%, significantly below the industry average of 83.9% [5][9] Financial Performance - In the first nine months of 2025, Ensign paid out $10.8 million in dividends and repurchased $20 million in stock during the first half of the year, although no repurchases occurred in the third quarter [2][9] - The Zacks Consensus Estimate projects a year-over-year earnings increase of 18.2% for 2025, with earnings expected to reach $6.50 per share, and a further increase of 9% to $7.09 per share in 2026 [3][4] Valuation Metrics - Ensign's shares have appreciated by 33.8% over the past year, outperforming the industry growth of 31.9% [8] - The company currently trades at a forward price-to-earnings ratio of 27.89, which is lower than the industry average of 50.23, indicating a potentially favorable valuation [10]

Core Viewpoint - Ensign Group (ENSG) has been upgraded to a Zacks Rank 2 (Buy), indicating an upward trend in earnings estimates which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system is based on changes in a company's earnings picture, which is a strong predictor of near-term stock price movements [2][4]. - Rising earnings estimates for Ensign Group suggest an improvement in the company's underlying business, likely leading to an increase in stock price [5][10]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a strong historical performance, particularly for Zacks Rank 1 stocks which have averaged a +25% annual return since 1988 [7]. - The system maintains a balanced distribution of ratings, ensuring that only the top 20% of stocks receive a "Strong Buy" or "Buy" rating, indicating superior earnings estimate revisions [9][10]. Earnings Estimate Revisions for Ensign Group - For the fiscal year ending December 2025, Ensign Group is expected to earn $6.50 per share, with a 1.4% increase in the Zacks Consensus Estimate over the past three months [8].

Core Viewpoint - The Ensign Group, Inc. has declared a quarterly cash dividend of $0.0650 per share, marking its twenty-third consecutive annual dividend increase, reflecting a strong market position and commitment to shareholder value [1]. Company Overview - The Ensign Group, Inc. operates independent subsidiaries that provide a wide range of skilled nursing and senior living services, as well as physical, occupational, and speech therapies across 373 healthcare facilities in various states including Alabama, California, and Texas [3]. - The company has been a dividend-paying entity since 2002, indicating a long-standing commitment to returning value to shareholders [2]. Financial Information - The dividend is payable on or before January 31, 2026, to shareholders of record as of December 31, 2025 [1].

Group 1 - Ensign Group Inc. shares are currently trading at $170.49, reflecting a 2.10% drop in the current session and a 3.75% decrease over the past month, while showing a 22.48% increase over the past year [1] - The company's price-to-earnings (P/E) ratio is 31.15, which is significantly higher than the aggregate P/E ratio of 15.22 for the Health Care Providers & Services industry, suggesting that Ensign Group may be expected to perform better than its industry peers [6] - A higher P/E ratio may indicate that the stock is overvalued, but it could also reflect investor optimism regarding future performance and potential dividend increases [5][6] Group 2 - The P/E ratio is a useful metric for evaluating a company's market performance, but it should be used cautiously as a low P/E can indicate undervaluation or weak growth prospects [9][10] - Investors should consider the P/E ratio alongside other financial ratios, industry trends, and qualitative factors to make well-informed investment decisions [10]

Core Viewpoint - Growth stocks are appealing due to their potential for above-average financial growth, but identifying those that can fulfill their potential is challenging due to associated risks and volatility [1] Group 1: Company Overview - Ensign Group (ENSG) is identified as a promising growth stock with a favorable Growth Score and a top Zacks Rank [2] - The company provides nursing and rehabilitative care services, positioning it well within the healthcare sector [3] Group 2: Earnings Growth - Ensign Group has a historical EPS growth rate of 14.5%, with projected EPS growth of 29.8% this year, significantly outperforming the industry average of 2.5% [4] Group 3: Cash Flow Growth - The company exhibits a year-over-year cash flow growth of 15.8%, surpassing the industry average of 9.4% [5] - Over the past 3-5 years, Ensign Group's annualized cash flow growth rate has been 17.4%, compared to the industry average of 5.8% [6] Group 4: Earnings Estimate Revisions - Current-year earnings estimates for Ensign Group have been revised upward, with the Zacks Consensus Estimate increasing by 1% over the past month, indicating positive momentum [7] Group 5: Investment Positioning - Ensign Group holds a Growth Score of B and a Zacks Rank of 2, reflecting positive earnings estimate revisions and positioning the company for potential outperformance [9]